Valuation: Eurofins Cerep

Market Cap 75.66M 83.04M 70.04M 63.35M 119M 7.76B 124M 847M 336M 4.19B 312M 305M 13.28B P/E 2024 *
-
P/E 2025 -
Enterprise Value 54.63M 59.96M 50.57M 45.74M 85.8M 5.6B 89.81M 611M 242M 3.03B 225M 220M 9.58B EV / Sales 2024
2.02x
EV / Sales 2025 1.67x
Free-Float
4.22%
Yield 2024 *
-
Yield 2025 -
1 week-18.48%
Current month-18.48%
1 month-18.48%
3 months-7.98%
6 months-5.66%
Current year-15.73%
1 week 15,000
Extreme 15000
18,400
1 month 15,000
Extreme 15000
18,400
Current year 15,000
Extreme 15000
18,600
1 year 15,000
Extreme 15000
18,600
3 years 15,000
Extreme 15000
25,000
5 years 15,000
Extreme 15000
29,200
10 years 4,300
Extreme 4300
29,200
Manager TitleAgeSince
Chief Executive Officer - 10/04/2024
Director TitleAgeSince
Chairman - 10/08/2023
Director/Board Member - 22/05/2024
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-18.48%-6.83%-40.00% 83.04M
-2.49%-6.35%+51.07%+64.95% 65.42B
-0.23%-2.48%+6.67%+90.06% 58.91B
-2.07%-1.95%+23.21%+82.81% 55.24B
-0.48%-4.88%+13.44%+110.90% 45.66B
-0.60%-5.56%+15.32%+21.96% 41.29B
-0.93%+1.67%+20.83%+45.03% 36.82B
+3.97%-3.57%+137.75%+664.57% 34.48B
-0.17%+1.51%+78.85%+57.66% 32.5B
-0.43%+20.81%-26.68%+494.54% 31.69B
Average -0.26%-2.44%+31.36%+159.25% 40B
Weighted average by Cap. -0.56%-1.28%+33.56%+154.73%

Financials

2024 2025
Net sales 40.49M 44.44M 37.48M 33.9M 63.6M 4.15B 66.56M 453M 180M 2.24B 167M 163M 7.1B 41.1M 45.11M 38.04M 34.41M 64.56M 4.21B 67.57M 460M 182M 2.28B 169M 166M 7.21B
Net income 7.15M 7.85M 6.62M 5.99M 11.24M 733M 11.76M 80.06M 31.76M 396M 29.46M 28.84M 1.26B 4.78M 5.25M 4.43M 4M 7.51M 490M 7.86M 53.51M 21.23M 265M 19.69M 19.28M 839M
Net Debt -17.25M -18.94M -15.97M -14.45M -27.1M -1.77B -28.36M -193M -76.58M -956M -71.04M -69.56M -3.03B -21.03M -23.09M -19.47M -17.61M -33.04M -2.16B -34.58M -235M -93.37M -1.17B -86.62M -84.8M -3.69B
Projected Income Statement - Annual - Eurofins Cerep
Logo Eurofins Cerep
Eurofins Cerep specializes in the pre-clinical research of drugs for the pharmaceutical industry. Export accounts for 88.2% of net sales.
Employees
197
Date Price Change
19/11/26 €15,000.00 0.00%
18/11/26 €15,000.00 0.00%
17/11/26 €15,000.00 -18.48%
16/11/26 €18,400.00 0.00%
13/11/26 €18,400.00 0.00%
  1. Stock Market
  2. Stocks
  3. ALECR Stock